glp-1 news september 2025 Alarming rise in weight loss drug overdoses glp-1 obesity drug news today

Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells

Understanding the relationship between GLP-1 medications and skin reactions helps patients distinguish between documented adverse effects, injection site reactions, and changes related to weight loss

I don't think the way the FDA has done this has been productive. The APC, which represents over 600 compounding pharmacies in the US, has sent a letter to the FDA urging it to use enforcement discretion and allow compounders an extended off-ramp to help transition patients

You have your 365-Day Love It or Your Money Back Guarantee

Instead, the drug overrode the system

Studies on long-term use, adherence, and related potential side-effects do not exist